Streetbeat News

Analyst Ratings

APA

Citigroup analyst Scott Gruber has downgraded APA Corporation (NASDAQ:APA) from Buy to Neutral and reduced the price target from $52 to $37.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:52 am

IQ

JP Morgan analyst Daniel Chen downgraded iQIYI (NASDAQ:IQ) from Overweight to Neutral and set a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:50 am

OVV

Citigroup analyst Brian Downey upgraded Ovintiv (NYSE:OVV) from Neutral to Buy and increased the price target from $48 to $52, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:49 am

NVDA

Nvidia Corp. (NASDAQ:NVDA) experienced a premarket reversal, recovering from earlier losses and Tuesday's after-hours trading decline. This change in direction occurred after analysts dismissed concerns about China that Nvidia highlighted, focusing instead on the company's strong quarterly earnings. Nvidia reported Q3 non-GAAP earnings of $4.02 per share on revenue of $18.12 billion, surpassing consensus estimates. The company's record Data Center revenues were driven by demand for accelerated computing and generative AI. Despite anticipating lower contributions from China due to U.S. export restrictions, Nvidia expects to compensate with robust global demand. The company's Q4 revenue guidance of $20 billion is ahead of consensus estimates but below the whisper number. KeyBanc analyst John Vinh maintained an Outperform rating with a $650 price target. Nvidia's stock rose 1.35% to $506.20 in premarket trading on Wednesday.

Portfolio Pulse from Shanthi Rexaline

November 22, 2023 | 11:46 am

ARQQ

HC Wainwright & Co. analyst Scott Buck has maintained a Buy rating on Arqit Quantum (NASDAQ:ARQQ) but has reduced the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:44 am

MDWD

HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on MediWound (NASDAQ:MDWD) and maintained a $26 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:35 am

EDSA

HC Wainwright & Co. analyst Vernon Bernardino reaffirmed a Buy rating on Edesa Biotech (NASDAQ:EDSA) and maintained a $10 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:34 am

CLDI

HC Wainwright & Co. analyst Robert Burns has initiated coverage on Calidi Biotherapeutics (AMEX:CLDI) with a Buy rating and set a price target of $11.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:26 am

BDTX

HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Black Diamond Therapeutics (NASDAQ:BDTX) and maintained an $11 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:25 am

NUVB

HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Nuvation Bio (NYSE:NUVB) and maintained a price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

November 22, 2023 | 11:19 am